A new edition of World Alzheimer Report, to be published Sept. 20, 2024, will take a deep dive into how perceptions of dementia have changed over the past five years. It builds on a 2019 report...
Despite extensive research and encouraging findings, Alzheimer’s disease (AD) remains difficult to diagnose based on signs and symptoms alone. But what if one day, a blood sample during an annual...
U.S. government health officials approved the first new drug for Alzheimer's disease in nearly 20 years, disregarding warnings from independent advisers that the much-debated treatment hasn't been...
Doctors who work with individuals at risk of developing dementia have long suspected that patients who do not realize they experience memory problems are at greater risk of seeing their condition...
New research has drawn a link between changes in the brain’s anatomy and biomarkers that are known to appear at the earliest stages of Alzheimer’s disease (AD), findings that could one day provide...
Imagine if doctors could determine, many years in advance, who is likely to develop dementia. Such prognostic capabilities would give patients and their families time to plan and manage treatment...